Name: Latest research reports of Dr. Reddy's Laboratories Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Dr. Reddy's Laboratories Ltd.
Rating: 4
Author: ICICI Securities Limited

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
	04 Sep 2025	Dr. Reddy's Labs	Consensus Share Price Target	1262.20	1287.37	-	1.99	hold	pdf Detailed Estimates
	27 Jul 2023	Dr. Reddy's Labs	ICICI Securities Limited Reco Target	1262.20	6000.00	5475.65 (-76.95%)	Target met	Accumulate	pdf post cache	Broker Report Better volumes in US drives margins ICICI Securities Limited Dr. Reddy’s (DRL) delivered a strong beat in EBITDA and profit, driven by incremental sales from its base product portfolio and gRevlimid in the US. gRevlimid continues to lift overall margins; however, additional sales from products that are in shortage in the US improved base business margins in Q1FY24. pdf Copy Link Share on Share on Share on Share on Alert
	04 Jul 2023	Dr. Reddy's Labs	Sharekhan Target	1262.20	5963.00	5178.35 (-75.63%)	Target met	Buy	pdf post cache	Broker Report Dr Reddys Labs Sharekhan pdf Copy Link Share on Share on Share on Share on Alert
	23 Jun 2023	Dr. Reddy's Labs	Motilal Oswal Target	1262.20	4680.00	4993.90 (-74.73%)	Pre-Bonus/ Split	Neutral	pdf post cache	Broker Report Robust show in FY23; but outlook subdued Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	11 May 2023	Dr. Reddy's Labs	SMC online	1262.20		4532.00 (-72.15%)	Pre-Bonus/ Split	Results Update	pdf post cache	Broker Report Dr. Reddys Laboratories SMC online pdf Copy Link Share on Share on Share on Share on Alert
	11 May 2023	Dr. Reddy's Labs	ICICI Direct Target	1262.20	5520.00	4532.00 (-72.15%)	Target met	Buy	pdf post cache	Broker Report Dr Reddy's Laboratories ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	11 May 2023	Dr. Reddy's Labs	BOB Capital Markets Ltd. Target	1262.20	4900.00	4532.00 (-72.15%)	Target met	Hold	pdf post cache	Broker Report Dr Reddy's Labs (HOLD): Core business remains sluggish BOB Capital Markets Ltd. Q4 broadly in line as revenue/EBITDA grew 16%/35% YoY (-7%/-23% QoQ), albeit aided by one-offs pdf Copy Link Share on Share on Share on Share on Alert
	11 May 2023	Dr. Reddy's Labs	Axis Direct Reco	1262.20	5100.00	4532.00 (-72.15%)	Target met	Hold	pdf post cache	Broker Report Result Update:Dr Reddys Labs Axis Direct Company Outlook & Guidance: Q4FY22 results were week. However, we believe DRRD's strategy of in investing various businesses may provide growth in the long term. pdf Copy Link Share on Share on Share on Share on Alert
	11 May 2023	Dr. Reddy's Labs	Motilal Oswal Reco Target	1262.20	4500.00	4532.00 (-72.15%)	Target met	Neutral	pdf post cache	Broker Report Earnings growth to moderate after superior show in FY23 Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	11 May 2023	Dr. Reddy's Labs	Prabhudas Lilladhar Reco Target	1262.20	4500.00	4532.00 (-72.15%)	Target met	Sell	pdf post cache	Broker Report DR REDDY'S LABS Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	07 Feb 2023	Dr. Reddy's Labs	Geojit BNP Paribas Target	1262.20	5166.00	4440.25 (-71.57%)	Target met	Buy	pdf post cache	Broker Report DR. REDDY'S LABORATARIES Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
more loading

Dr. Reddy's Laboratories Ltd. share price target

Dr. Reddy's Laboratories Ltd. has an average share price target of 1278.56. The consensus estimate represents an upside of 1.30% from the last price of 1262.20. View 17 reports from 9 analysts offering long-term price targets for Dr. Reddy's Laboratories Ltd..

Better volumes in US drives margins

Dr Reddys Labs

Robust show in FY23; but outlook subdued

Dr. Reddys Laboratories

Dr Reddy's Laboratories

Dr Reddy's Labs (HOLD): Core business remains sluggish

Result Update:Dr Reddys Labs

Earnings growth to moderate after superior show in FY23

DR REDDY'S LABS

DR. REDDY'S LABORATARIES

Advisor Screeners